Publication

The Effect of Levodopa on Vowel Articulation in Parkinson's Disease: A Cross-Linguistic Study

Jacobi, J., Rebernik, T., Jonkers, R., Maassen, B., Proctor, M. & Wieling, M., 2019, Proceedings of the 19th International Congress of Phonetic Sciences, Melbourne, Australia 2019 . Calhoun et al., S. (ed.). Australasian Speech Science and Technology Association Inc., p. 1069-1073 5 p.

Research output: Chapter in Book/Report/Conference proceedingConference contributionAcademicpeer-review

APA

Jacobi, J., Rebernik, T., Jonkers, R., Maassen, B., Proctor, M., & Wieling, M. (2019). The Effect of Levodopa on Vowel Articulation in Parkinson's Disease: A Cross-Linguistic Study. In S. Calhoun et al. (Ed.), Proceedings of the 19th International Congress of Phonetic Sciences, Melbourne, Australia 2019 (pp. 1069-1073). Australasian Speech Science and Technology Association Inc..

Author

Jacobi, Jidde ; Rebernik, Teja ; Jonkers, Roel ; Maassen, Bernardus ; Proctor, Michael ; Wieling, Martijn. / The Effect of Levodopa on Vowel Articulation in Parkinson's Disease : A Cross-Linguistic Study. Proceedings of the 19th International Congress of Phonetic Sciences, Melbourne, Australia 2019 . editor / Sasha Calhoun et al. Australasian Speech Science and Technology Association Inc., 2019. pp. 1069-1073

Harvard

Jacobi, J, Rebernik, T, Jonkers, R, Maassen, B, Proctor, M & Wieling, M 2019, The Effect of Levodopa on Vowel Articulation in Parkinson's Disease: A Cross-Linguistic Study. in S Calhoun et al. (ed.), Proceedings of the 19th International Congress of Phonetic Sciences, Melbourne, Australia 2019 . Australasian Speech Science and Technology Association Inc., pp. 1069-1073.

Standard

The Effect of Levodopa on Vowel Articulation in Parkinson's Disease : A Cross-Linguistic Study. / Jacobi, Jidde; Rebernik, Teja; Jonkers, Roel; Maassen, Bernardus; Proctor, Michael; Wieling, Martijn.

Proceedings of the 19th International Congress of Phonetic Sciences, Melbourne, Australia 2019 . ed. / Sasha Calhoun et al. Australasian Speech Science and Technology Association Inc., 2019. p. 1069-1073.

Research output: Chapter in Book/Report/Conference proceedingConference contributionAcademicpeer-review

Vancouver

Jacobi J, Rebernik T, Jonkers R, Maassen B, Proctor M, Wieling M. The Effect of Levodopa on Vowel Articulation in Parkinson's Disease: A Cross-Linguistic Study. In Calhoun et al. S, editor, Proceedings of the 19th International Congress of Phonetic Sciences, Melbourne, Australia 2019 . Australasian Speech Science and Technology Association Inc. 2019. p. 1069-1073


BibTeX

@inproceedings{222416f20bfd4ef29508d2f7ae877317,
title = "The Effect of Levodopa on Vowel Articulation in Parkinson's Disease: A Cross-Linguistic Study",
abstract = "Parkinson's disease (PD) is a neurological disorderthat is characterized by a decay in global motorperformance, manifest in tremor, abnormal gait, anddysarthria. PD dysarthria characteristics includemonoloudness, pathological voice quality, andimprecise articulation. Standard treatment forrelieving PD symptoms is the drug Levodopa, but itis currently unknown how it affects speech. Weinvestigated the effect of Levodopa on the vowelspace of 4 Dutch and 6 Slovenian PD participants.They recorded their speech on twenty occasionsdistributed over four days across 2-4 weeks. First andsecond formants of corner vowels [i-a-u] produced inisolated words were measured at acoustic midpointsof 4043 tokens. VAI [13], a metric of vowel spacedispersion, was calculated for each speaker. VAI wasnot significantly affected by Levodopa in eitherlanguage, which may indicate that the motor controlunderlying vowel articulation is not as sensitive toLevodopa as other motor symptoms",
author = "Jidde Jacobi and Teja Rebernik and Roel Jonkers and Bernardus Maassen and Michael Proctor and Martijn Wieling",
year = "2019",
language = "English",
pages = "1069--1073",
editor = "{Calhoun et al.}, {Sasha }",
booktitle = "Proceedings of the 19th International Congress of Phonetic Sciences, Melbourne, Australia 2019",
publisher = "Australasian Speech Science and Technology Association Inc.",

}

RIS

TY - GEN

T1 - The Effect of Levodopa on Vowel Articulation in Parkinson's Disease

T2 - A Cross-Linguistic Study

AU - Jacobi, Jidde

AU - Rebernik, Teja

AU - Jonkers, Roel

AU - Maassen, Bernardus

AU - Proctor, Michael

AU - Wieling, Martijn

PY - 2019

Y1 - 2019

N2 - Parkinson's disease (PD) is a neurological disorderthat is characterized by a decay in global motorperformance, manifest in tremor, abnormal gait, anddysarthria. PD dysarthria characteristics includemonoloudness, pathological voice quality, andimprecise articulation. Standard treatment forrelieving PD symptoms is the drug Levodopa, but itis currently unknown how it affects speech. Weinvestigated the effect of Levodopa on the vowelspace of 4 Dutch and 6 Slovenian PD participants.They recorded their speech on twenty occasionsdistributed over four days across 2-4 weeks. First andsecond formants of corner vowels [i-a-u] produced inisolated words were measured at acoustic midpointsof 4043 tokens. VAI [13], a metric of vowel spacedispersion, was calculated for each speaker. VAI wasnot significantly affected by Levodopa in eitherlanguage, which may indicate that the motor controlunderlying vowel articulation is not as sensitive toLevodopa as other motor symptoms

AB - Parkinson's disease (PD) is a neurological disorderthat is characterized by a decay in global motorperformance, manifest in tremor, abnormal gait, anddysarthria. PD dysarthria characteristics includemonoloudness, pathological voice quality, andimprecise articulation. Standard treatment forrelieving PD symptoms is the drug Levodopa, but itis currently unknown how it affects speech. Weinvestigated the effect of Levodopa on the vowelspace of 4 Dutch and 6 Slovenian PD participants.They recorded their speech on twenty occasionsdistributed over four days across 2-4 weeks. First andsecond formants of corner vowels [i-a-u] produced inisolated words were measured at acoustic midpointsof 4043 tokens. VAI [13], a metric of vowel spacedispersion, was calculated for each speaker. VAI wasnot significantly affected by Levodopa in eitherlanguage, which may indicate that the motor controlunderlying vowel articulation is not as sensitive toLevodopa as other motor symptoms

UR - http://www.martijnwieling.nl/files/Jacobi2019.pdf

UR - https://www.icphs2019.org/

M3 - Conference contribution

SP - 1069

EP - 1073

BT - Proceedings of the 19th International Congress of Phonetic Sciences, Melbourne, Australia 2019

A2 - Calhoun et al., Sasha

PB - Australasian Speech Science and Technology Association Inc.

ER -

ID: 108280437